Association of Systemic Inflammatory Markers With Endometrioma Diagnosis and Douglas Involvement: A Retrospective Analysis

In: Research Square · 2025 · doi:10.21203/rs.3.rs-7623083/v1 · W4415490093
preprint OA: green CC0
📄 Open PDF View on OpenAlex View at publisher
AI-generated summary by claude@2026-06+body, 2026-06-08

This retrospective analysis found that hematological inflammatory markers like SIRI, NLR, PLR, and SII were significantly higher in endometrioma patients, with SIRI most effective at distinguishing endometriomas from other benign ovarian cysts.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometrioma

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (21)

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK